Anti-cyclic citrullinated peptide-2 (CCP2) autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2008-04

AUTHORS

Ioannis Alexiou, Anastasios Germenis, Athanasios Koutroumpas, Anastasia Kontogianni, Katerina Theodoridou, Lazaros I. Sakkas

ABSTRACT

The objective of our study was to establish whether there is an association between rheumatoid arthritis with extra-articular manifestations (exRA) and anti-cyclic citrullinated peptide 2 (anti-CCP2) antibodies in Greeks. A retrospective study of 220 Greek patients with RA, 95 with exRA and 125 without extra-articular manifestations (cRA). Serum anti-CCP2 antibodies and IgM rheumatoid factor (RF) were measured. CCP2(+) were 65.3% of exRA and 58.4% of cRA patients. RF(+) were 69.5% of exRA and 60.0% of cRA patients. Among exRA patients, 37.9% had high serum anti-CCP2 antibody levels (>100 IU/ml) compared to 21.6% cRA patients (p = 0.008). Serositis and pulmonary fibrosis were found to be associated with high levels of anti-CCP2 antibodies (52.9 vs 26.6%, p = 0.02 and 63.6 vs 26.8%, p = 0.008, respectively). Serum RF levels were 265.0 +/- 52.0 IU/ml (mean +/- SEM) in exRA and 205.1 +/- 40.6 (mean +/- SEM) in cRA (NS). High serum RF levels (>268 IU/ml) were more likely to have sicca syndrome. In Greek patients with rheumatoid arthritis (RA), high serum anti-CCP2 antibodies are associated with serositis and pulmonary fibrosis. Therefore, anti-CCP2 antibodies have prognostic significance in patients with RA. More... »

PAGES

511-513

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10067-007-0800-1

DOI

http://dx.doi.org/10.1007/s10067-007-0800-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1025478929

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18172572


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Arthritis, Rheumatoid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Autoantibodies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Felty Syndrome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Greece", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Peptides, Cyclic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pulmonary Fibrosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Raynaud Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rheumatoid Factor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rheumatoid Nodule", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Serositis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sjogren's Syndrome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vasculitis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University Hospital of Larissa", 
          "id": "https://www.grid.ac/institutes/grid.411299.6", 
          "name": [
            "Department of Medicine/Rheumatology, University Hospital of Larisa, 41 110, Larisa, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Alexiou", 
        "givenName": "Ioannis", 
        "id": "sg:person.01367341047.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01367341047.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Of Thessaly", 
          "id": "https://www.grid.ac/institutes/grid.410558.d", 
          "name": [
            "Laboratory of Immunology and Histocompatibility, Thessaly University Medical School, 41 110, Larisa, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Germenis", 
        "givenName": "Anastasios", 
        "id": "sg:person.01067210351.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067210351.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Hospital of Larissa", 
          "id": "https://www.grid.ac/institutes/grid.411299.6", 
          "name": [
            "Department of Medicine/Rheumatology, University Hospital of Larisa, 41 110, Larisa, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Koutroumpas", 
        "givenName": "Athanasios", 
        "id": "sg:person.0712353407.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0712353407.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Hospital of Larissa", 
          "id": "https://www.grid.ac/institutes/grid.411299.6", 
          "name": [
            "Department of Medicine/Rheumatology, University Hospital of Larisa, 41 110, Larisa, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kontogianni", 
        "givenName": "Anastasia", 
        "id": "sg:person.0630274757.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630274757.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Of Thessaly", 
          "id": "https://www.grid.ac/institutes/grid.410558.d", 
          "name": [
            "Laboratory of Immunology and Histocompatibility, Thessaly University Medical School, 41 110, Larisa, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Theodoridou", 
        "givenName": "Katerina", 
        "id": "sg:person.0676410157.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676410157.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Hospital of Larissa", 
          "id": "https://www.grid.ac/institutes/grid.411299.6", 
          "name": [
            "Department of Medicine/Rheumatology, University Hospital of Larisa, 41 110, Larisa, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sakkas", 
        "givenName": "Lazaros I.", 
        "id": "sg:person.0744523357.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744523357.41"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/art.1780350706", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000388407"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.21739", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004491247"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.21739", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004491247"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/ard.55.3.190", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013793254"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/ard.2003.014647", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014199756"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/ard.2004.033571", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022871973"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/ard.2006.054445", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030149837"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00296-004-0571-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034653442", 
          "https://doi.org/10.1007/s00296-004-0571-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00296-004-0571-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034653442", 
          "https://doi.org/10.1007/s00296-004-0571-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.20316", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034966177"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/rheumatology/36.1.141", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037780461"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/rheumatology/kei111", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041090640"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.10705", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042282438"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.clinbiochem.2006.06.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042674950"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2474-8-37", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045542963", 
          "https://doi.org/10.1186/1471-2474-8-37"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/ard.2003.017574", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047283911"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.22597", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047918691"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.21575", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048876080"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.21575", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048876080"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-146-11-200706050-00008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073709069"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2008-04", 
    "datePublishedReg": "2008-04-01", 
    "description": "The objective of our study was to establish whether there is an association between rheumatoid arthritis with extra-articular manifestations (exRA) and anti-cyclic citrullinated peptide 2 (anti-CCP2) antibodies in Greeks. A retrospective study of 220 Greek patients with RA, 95 with exRA and 125 without extra-articular manifestations (cRA). Serum anti-CCP2 antibodies and IgM rheumatoid factor (RF) were measured. CCP2(+) were 65.3% of exRA and 58.4% of cRA patients. RF(+) were 69.5% of exRA and 60.0% of cRA patients. Among exRA patients, 37.9% had high serum anti-CCP2 antibody levels (>100 IU/ml) compared to 21.6% cRA patients (p = 0.008). Serositis and pulmonary fibrosis were found to be associated with high levels of anti-CCP2 antibodies (52.9 vs 26.6%, p = 0.02 and 63.6 vs 26.8%, p = 0.008, respectively). Serum RF levels were 265.0 +/- 52.0 IU/ml (mean +/- SEM) in exRA and 205.1 +/- 40.6 (mean +/- SEM) in cRA (NS). High serum RF levels (>268 IU/ml) were more likely to have sicca syndrome. In Greek patients with rheumatoid arthritis (RA), high serum anti-CCP2 antibodies are associated with serositis and pulmonary fibrosis. Therefore, anti-CCP2 antibodies have prognostic significance in patients with RA.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s10067-007-0800-1", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1093299", 
        "issn": [
          "0770-3198", 
          "1434-9949"
        ], 
        "name": "Clinical Rheumatology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "27"
      }
    ], 
    "name": "Anti-cyclic citrullinated peptide-2 (CCP2) autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis", 
    "pagination": "511-513", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "7962512f3a831bfc987be0373d04d25b51aca06a8c78ca93c1af934d6c4714d0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18172572"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8211469"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10067-007-0800-1"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1025478929"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10067-007-0800-1", 
      "https://app.dimensions.ai/details/publication/pub.1025478929"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T14:33", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000373_0000000373/records_13106_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs10067-007-0800-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10067-007-0800-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10067-007-0800-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10067-007-0800-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10067-007-0800-1'


 

This table displays all metadata directly associated to this object as RDF triples.

228 TRIPLES      21 PREDICATES      63 URIs      38 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10067-007-0800-1 schema:about N28bac05e8e89451c8b8b7ffc95691725
2 N3395720e9c964d0b9ddedee251d3522d
3 N36bce882dc574912ac764a02352317e3
4 N48ae18de98624faaa64000ed9074c96c
5 N6b9e004dfd0a4413a5de94b990dc768f
6 N752237528ce74df8a82cdbcce5cef6cd
7 N7dfcb5faf1b248e0aba3cc0506c59912
8 N8671ff80ec744f54a33b2ac029d134cd
9 N88df87a33a0c47148f31d95b8edfd6b2
10 N929bfdc2244b401ab70dc0b5e0650004
11 Nc38ddba13a944f4687a7aafd5e15a835
12 Ncc7ecec1203348f395be2819c7675855
13 Nd81558bc7b25460f8e824de4ad692d3a
14 Nd92bc11477124f5d9fa5e3284db99ad7
15 Nde98d3a63a9340ec801e39781fdd56d0
16 Nf213ff17a6fe41e6844b15bf8f2b9b12
17 Nf4020fa5db3c485793d48b6c9c553c62
18 anzsrc-for:11
19 anzsrc-for:1103
20 schema:author Nb2720ef68d794aeeb71cb67f0e9223b9
21 schema:citation sg:pub.10.1007/s00296-004-0571-9
22 sg:pub.10.1186/1471-2474-8-37
23 https://doi.org/10.1002/art.10705
24 https://doi.org/10.1002/art.1780350706
25 https://doi.org/10.1002/art.20316
26 https://doi.org/10.1002/art.21575
27 https://doi.org/10.1002/art.21739
28 https://doi.org/10.1002/art.22597
29 https://doi.org/10.1016/j.clinbiochem.2006.06.004
30 https://doi.org/10.1093/rheumatology/36.1.141
31 https://doi.org/10.1093/rheumatology/kei111
32 https://doi.org/10.1136/ard.2003.014647
33 https://doi.org/10.1136/ard.2003.017574
34 https://doi.org/10.1136/ard.2004.033571
35 https://doi.org/10.1136/ard.2006.054445
36 https://doi.org/10.1136/ard.55.3.190
37 https://doi.org/10.7326/0003-4819-146-11-200706050-00008
38 schema:datePublished 2008-04
39 schema:datePublishedReg 2008-04-01
40 schema:description The objective of our study was to establish whether there is an association between rheumatoid arthritis with extra-articular manifestations (exRA) and anti-cyclic citrullinated peptide 2 (anti-CCP2) antibodies in Greeks. A retrospective study of 220 Greek patients with RA, 95 with exRA and 125 without extra-articular manifestations (cRA). Serum anti-CCP2 antibodies and IgM rheumatoid factor (RF) were measured. CCP2(+) were 65.3% of exRA and 58.4% of cRA patients. RF(+) were 69.5% of exRA and 60.0% of cRA patients. Among exRA patients, 37.9% had high serum anti-CCP2 antibody levels (>100 IU/ml) compared to 21.6% cRA patients (p = 0.008). Serositis and pulmonary fibrosis were found to be associated with high levels of anti-CCP2 antibodies (52.9 vs 26.6%, p = 0.02 and 63.6 vs 26.8%, p = 0.008, respectively). Serum RF levels were 265.0 +/- 52.0 IU/ml (mean +/- SEM) in exRA and 205.1 +/- 40.6 (mean +/- SEM) in cRA (NS). High serum RF levels (>268 IU/ml) were more likely to have sicca syndrome. In Greek patients with rheumatoid arthritis (RA), high serum anti-CCP2 antibodies are associated with serositis and pulmonary fibrosis. Therefore, anti-CCP2 antibodies have prognostic significance in patients with RA.
41 schema:genre research_article
42 schema:inLanguage en
43 schema:isAccessibleForFree false
44 schema:isPartOf Nda8e3a763e4f429f90000299bc95aebd
45 Nfdb0064213c64f519b76f91d7155a95e
46 sg:journal.1093299
47 schema:name Anti-cyclic citrullinated peptide-2 (CCP2) autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis
48 schema:pagination 511-513
49 schema:productId N18eb0388072b4295a27308b7eae49e9e
50 N7ab2a67fdb034a7dae7ba734c06fccae
51 N8637d9a5365645f5912378d6c936dbb8
52 Ndf4f5fa51c944f388b6ee00ff6f21e2d
53 Nf43c514809574d04944870f522c7f657
54 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025478929
55 https://doi.org/10.1007/s10067-007-0800-1
56 schema:sdDatePublished 2019-04-11T14:33
57 schema:sdLicense https://scigraph.springernature.com/explorer/license/
58 schema:sdPublisher Na24d8cac812e4c869764a34d9466cd56
59 schema:url http://link.springer.com/10.1007%2Fs10067-007-0800-1
60 sgo:license sg:explorer/license/
61 sgo:sdDataset articles
62 rdf:type schema:ScholarlyArticle
63 N18eb0388072b4295a27308b7eae49e9e schema:name readcube_id
64 schema:value 7962512f3a831bfc987be0373d04d25b51aca06a8c78ca93c1af934d6c4714d0
65 rdf:type schema:PropertyValue
66 N28bac05e8e89451c8b8b7ffc95691725 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
67 schema:name Felty Syndrome
68 rdf:type schema:DefinedTerm
69 N3395720e9c964d0b9ddedee251d3522d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Serositis
71 rdf:type schema:DefinedTerm
72 N36bce882dc574912ac764a02352317e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Rheumatoid Nodule
74 rdf:type schema:DefinedTerm
75 N48ae18de98624faaa64000ed9074c96c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Retrospective Studies
77 rdf:type schema:DefinedTerm
78 N5157ec0c533f4eab85df7f82accaea1c rdf:first sg:person.0712353407.69
79 rdf:rest Nc0c9d0bbf0e54db490c6b0b71ced7099
80 N61ea31a8915c4afd95624e5fbedf16f8 rdf:first sg:person.0744523357.41
81 rdf:rest rdf:nil
82 N6923f7d9b3a24ac8853b3d90fe4352af rdf:first sg:person.0676410157.13
83 rdf:rest N61ea31a8915c4afd95624e5fbedf16f8
84 N6b9e004dfd0a4413a5de94b990dc768f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Aged
86 rdf:type schema:DefinedTerm
87 N752237528ce74df8a82cdbcce5cef6cd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Rheumatoid Factor
89 rdf:type schema:DefinedTerm
90 N7ab2a67fdb034a7dae7ba734c06fccae schema:name nlm_unique_id
91 schema:value 8211469
92 rdf:type schema:PropertyValue
93 N7dfcb5faf1b248e0aba3cc0506c59912 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Vasculitis
95 rdf:type schema:DefinedTerm
96 N8637d9a5365645f5912378d6c936dbb8 schema:name pubmed_id
97 schema:value 18172572
98 rdf:type schema:PropertyValue
99 N8671ff80ec744f54a33b2ac029d134cd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Pulmonary Fibrosis
101 rdf:type schema:DefinedTerm
102 N88df87a33a0c47148f31d95b8edfd6b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Humans
104 rdf:type schema:DefinedTerm
105 N929bfdc2244b401ab70dc0b5e0650004 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Autoantibodies
107 rdf:type schema:DefinedTerm
108 Na24d8cac812e4c869764a34d9466cd56 schema:name Springer Nature - SN SciGraph project
109 rdf:type schema:Organization
110 Nb2720ef68d794aeeb71cb67f0e9223b9 rdf:first sg:person.01367341047.22
111 rdf:rest Ne7b0978bb6734e409df404cc70e921f3
112 Nc0c9d0bbf0e54db490c6b0b71ced7099 rdf:first sg:person.0630274757.26
113 rdf:rest N6923f7d9b3a24ac8853b3d90fe4352af
114 Nc38ddba13a944f4687a7aafd5e15a835 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Greece
116 rdf:type schema:DefinedTerm
117 Ncc7ecec1203348f395be2819c7675855 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Sjogren's Syndrome
119 rdf:type schema:DefinedTerm
120 Nd81558bc7b25460f8e824de4ad692d3a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Arthritis, Rheumatoid
122 rdf:type schema:DefinedTerm
123 Nd92bc11477124f5d9fa5e3284db99ad7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Raynaud Disease
125 rdf:type schema:DefinedTerm
126 Nda8e3a763e4f429f90000299bc95aebd schema:issueNumber 4
127 rdf:type schema:PublicationIssue
128 Nde98d3a63a9340ec801e39781fdd56d0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Peptides, Cyclic
130 rdf:type schema:DefinedTerm
131 Ndf4f5fa51c944f388b6ee00ff6f21e2d schema:name dimensions_id
132 schema:value pub.1025478929
133 rdf:type schema:PropertyValue
134 Ne7b0978bb6734e409df404cc70e921f3 rdf:first sg:person.01067210351.86
135 rdf:rest N5157ec0c533f4eab85df7f82accaea1c
136 Nf213ff17a6fe41e6844b15bf8f2b9b12 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Middle Aged
138 rdf:type schema:DefinedTerm
139 Nf4020fa5db3c485793d48b6c9c553c62 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Prognosis
141 rdf:type schema:DefinedTerm
142 Nf43c514809574d04944870f522c7f657 schema:name doi
143 schema:value 10.1007/s10067-007-0800-1
144 rdf:type schema:PropertyValue
145 Nfdb0064213c64f519b76f91d7155a95e schema:volumeNumber 27
146 rdf:type schema:PublicationVolume
147 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
148 schema:name Medical and Health Sciences
149 rdf:type schema:DefinedTerm
150 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
151 schema:name Clinical Sciences
152 rdf:type schema:DefinedTerm
153 sg:journal.1093299 schema:issn 0770-3198
154 1434-9949
155 schema:name Clinical Rheumatology
156 rdf:type schema:Periodical
157 sg:person.01067210351.86 schema:affiliation https://www.grid.ac/institutes/grid.410558.d
158 schema:familyName Germenis
159 schema:givenName Anastasios
160 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067210351.86
161 rdf:type schema:Person
162 sg:person.01367341047.22 schema:affiliation https://www.grid.ac/institutes/grid.411299.6
163 schema:familyName Alexiou
164 schema:givenName Ioannis
165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01367341047.22
166 rdf:type schema:Person
167 sg:person.0630274757.26 schema:affiliation https://www.grid.ac/institutes/grid.411299.6
168 schema:familyName Kontogianni
169 schema:givenName Anastasia
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630274757.26
171 rdf:type schema:Person
172 sg:person.0676410157.13 schema:affiliation https://www.grid.ac/institutes/grid.410558.d
173 schema:familyName Theodoridou
174 schema:givenName Katerina
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676410157.13
176 rdf:type schema:Person
177 sg:person.0712353407.69 schema:affiliation https://www.grid.ac/institutes/grid.411299.6
178 schema:familyName Koutroumpas
179 schema:givenName Athanasios
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0712353407.69
181 rdf:type schema:Person
182 sg:person.0744523357.41 schema:affiliation https://www.grid.ac/institutes/grid.411299.6
183 schema:familyName Sakkas
184 schema:givenName Lazaros I.
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744523357.41
186 rdf:type schema:Person
187 sg:pub.10.1007/s00296-004-0571-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034653442
188 https://doi.org/10.1007/s00296-004-0571-9
189 rdf:type schema:CreativeWork
190 sg:pub.10.1186/1471-2474-8-37 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045542963
191 https://doi.org/10.1186/1471-2474-8-37
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1002/art.10705 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042282438
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1002/art.1780350706 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000388407
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1002/art.20316 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034966177
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1002/art.21575 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048876080
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1002/art.21739 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004491247
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1002/art.22597 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047918691
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1016/j.clinbiochem.2006.06.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042674950
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1093/rheumatology/36.1.141 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037780461
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1093/rheumatology/kei111 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041090640
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1136/ard.2003.014647 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014199756
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1136/ard.2003.017574 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047283911
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1136/ard.2004.033571 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022871973
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1136/ard.2006.054445 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030149837
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1136/ard.55.3.190 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013793254
220 rdf:type schema:CreativeWork
221 https://doi.org/10.7326/0003-4819-146-11-200706050-00008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073709069
222 rdf:type schema:CreativeWork
223 https://www.grid.ac/institutes/grid.410558.d schema:alternateName University Of Thessaly
224 schema:name Laboratory of Immunology and Histocompatibility, Thessaly University Medical School, 41 110, Larisa, Greece
225 rdf:type schema:Organization
226 https://www.grid.ac/institutes/grid.411299.6 schema:alternateName University Hospital of Larissa
227 schema:name Department of Medicine/Rheumatology, University Hospital of Larisa, 41 110, Larisa, Greece
228 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...